Go to Home

NEWS

RECENT DEALS, ALLIANCES & NEWS

ProPharma assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new venture strategic planning, technology assessment and valuations, and financing of early and mid-stage companies.

Recent Deals and Alliances

The Partners of ProPharma actively facilitated the recent alliances:
Ascend Therapeutics Partners with Valeant Pharmaceuticals to promote Migranal® migraine product to OB/GYN physicians, October 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal® to OB/GYNs
Gemin X Biotechnologies and Leo Pharma
Gemin X Biotechnologies licenses world wide rights to GMX1777, a novel prodrug therapeutic for the treatment of refractory solid tumors and Lymphomas from Leo Pharma May 2007
ReGen and Metagenics
ReGen signs first commercial deal for Colostrinin
Cytogen Corporation and Inpharma AS
Cytogen Corporation licenses exclusive North American rights to Capsohol®, a treatment for the relief of pain associated with oral mucositis from InPharma AS
Asterand and BTG Adobe Acrobat PDF Document
BTG licenses analgesic compounds from Asterand
Sanochemia and Avigen Adobe Acrobat PDF Document
Avigen partners Sanochemia's tolperisone for the North American market.
ProPharma and Biolink International form Partnership
New partnership expands services and expertise
Miikana Therapeutics and Roche Adobe Acrobat PDF Document
Miikana licenses Phase II anticancer compound from Roche
Pfizer and Meridica Adobe Acrobat PDF Document
Pfizer's acquisition of Meridica
Enzon Pharmaceuticals, Inc. and Pharmagene
Cystic fibrosis treatment development collaboration
Cerylid Biosciences and Anadys Pharmaceuticals Adobe Acrobat PDF Document
Natural product chemistry collaboration
Metabolex and Yamanouchi (now known as Astellas) Adobe Acrobat PDF Document
Diabetes target discovery partnership
Replidyne, Inc and Sequoia Sciences Adobe Acrobat PDF Document
Compound/access screening collaboration
Daiichi Pharmaceuticals and Rigel Pharmaceuticals Adobe Acrobat PDF Document
Cancer focused drug discovery partnership

Recent News

ProPharma Partner, James Chubb, will chair a session on Wednesday, June 18 10:15-11:45 during the annual BIO meeting in San Diego. The session is entitled Extracting Value out of Your Early-Stage Pipeline. The Panelists will include Peter Condon, Genentech; Hugh Cowley, GSK; Don deBethizy, Targacept; and Gordon Shore, GeminX.
ProPharma Partner, Paulo Rangel, will participate on a panel at the Arrowhead Symposium entitled Pharma/Biotech Product Life Cycle Management Strategies at the La Jolla Marriott hotel February 27-28, 2008. Paulo's presentation is entitled: Targeted Drug Delivery as a means to improve drugs and manage product life cycle - A case study of the lung.
BIO (Biotechnology Industry Organization) has selected ProPharma for the 5th consecutive year to assist in organizing the 5th annual BIO-Asia Partnering Conference in Tokyo, January, 28-29 2008
BioAsia Partnering ConferenceBIO (Biotechnology Industry Organization) has selected ProPharma to assist in organizing the 4th annual BIO-Asia Partnering Conference scheduled for January 29 -30 2007.
ProPharma participates on partnering conference panel entitled "Strategies for Successful Partnering" at the San Jose BioCenter November 9 2006
ProPharma invited to present on "Product In-licensing Strategies" during the March 10, 2005 annual meeting of the Canadian Healthcare Licensing Association
ProPharma Presents at the BioPartnering North America Conference in Vancouver on February 8-10. 2004
ProPharma will be discussing its business development experience and strategies during the conference session entitled "The Dynamics of Asian Deal Making"
ProPharma Provides Organizational Support to BIO
BIO ( Biotechnology Industry Organization) engaged ProPharma to assist in the organization of BIOAsia, an industry partnering meeting to be held February 2-3, 2004 in Tokyo, Japan.
+1 510 681 4445